Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Biological characteristics of A-176120, a potent FPP mimetic with promise as a cancer therapeutic

July 12, 2000

AlphaOne enters agreement with Dana-Farber for tumor suppressor gene

July 12, 2000

Maxim licenses caspase-activating anticancer compounds to BioChem Pharma

July 11, 2000

Tumor antigen-specific chimeric proteins from Idec promote antitumor immune response

July 11, 2000

Shortened Taxol regimen approved by FDA for advanced ovarian cancer

July 11, 2000

Chemoprotective effects of KF-41399 demonstrated in nimustine-treated mice

July 11, 2000

New benzazepine selectively targets tumor cells and induces G2/M arrest and apoptosis

July 11, 2000

Angiostatin combined with radiation therapy enters phase I trials

July 11, 2000

SkyePharma grants Paladin exclusive Canadian rights for DepoCyt

July 10, 2000

Aronex files NDA amendment for Atragen as treatment for APL

July 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...